Faculty – 3rd Payer Partnership Forum


Barrie Baker, M.D., MBA
Chief Medical Officer, TUFTS HEALTH PUBLIC PLANS

view speaker profile

Dr. Baker has over 15 years’ experience in Medicaid Managed Care administration. As the Chief Medical Officer for the Public Plans Division of Tufts Health Plan, she is responsible for over 400,000 of Tufts’ Medicaid, Duals and Commercial Qualified Health Plan members. Prior to coming to Massachusetts, she also served as the medical director for Coventry’s Medicaid programs in Pennsylvania and Maryland, and as Senior Medical Director for Keystone Mercy Health Plan. Before joining the health insurance industry, Barrie spent seven years as a family physician in underserved areas.

Barrie earned her M.D. from the Medical College of Pennsylvania, an M.B.A. from Eastern University and a Bachelor of Architecture from Temple University. She is board certified in Family Practice. She has also presented numerous workshops & talks on Health Care Disparities and Cultural Diversity nationally over the past 20 years


Mike Barrett
Founder, CURA HEALTH MANAGEMENT

view speaker profile

Mike is responsible for business development and oversees the company’s ACOs in the southeast region. In addition to the oversight of these ACOs, Mike is responsible for program growth and development. He has more than 25 years of experience in managed care payer and provider operations, holding executive positions at large hospital systems, managed Medicare physician groups and HMOs. Prior to joining the company, Mike assisted in the turnaround of a large globally capitated “at risk” IPA in greater New York City serving Medicare, Medicaid, Commercial and ACO populations. Mike earned his B.S. degree from Syracuse University. Mike is Co-Chairman of the National Association of ACOs (NAACOS) and was one of the original founders of the association.


Fred Brownfield
Director, Pharma Innovative Contracting, HUMANA


Anita Burrell
Adjunct Professor, RUTGERS UNIVERSITY

view speaker profile

Anita Burrell is a dynamic, passionate and infectiously enthusiastic consultant focused on improving patient outcomes through pharmaceutical innovation. She is also an adjunct assistant professor at Rutgers University and a regular speaker in the industry on health economics, market access, and mHealth.

Anita has 23 years of leadership experience in the pharmaceutical industry in a wide variety of roles and geographies. As the Global Project Lead for Aubagio, the oral MS therapy from Genzyme, she was able to bring Aubagio to market over eight months ahead of schedule becoming the second oral therapy to market in the USA and EU. Aubagio is the fastest growing MS product in the US and the #1 product in the Genzyme/Sanofi portfolio with revenue of €1.3B in 2016.

As a consultant, Anita has helped companies to:

  • Understand market dynamics and payer behavior in diabetes and MS
  • Design big data platforms to deliver value in terms of regional sales variations
  • Develop predictive models to inform HTA submissions
  • Understand the implications of digital health and possibilities to use behavioral economics

Anita holds a BA (Hons) in Economics from the University of Stirling, an M.A. in Economics from Dalhousie University, Nova Scotia, Canada, and a Masters in Business Administration from Kingston University, Surrey UK. She speaks French at an advanced level.

For more insight visit https://www.linkedin.com/in/anitaburrell

Transitioning From Corporate to Consultant

  • Left my role at Sanofi in March 2015
  • Difficult to find VP roles and did not want to join big pharma
  • Consulting was an option but I was scared
  • What if no-one will pay for my advice?
  • Setting your rate
  • How do I set up a company?
  • Will it affect my family?
  • Legal implications – LLC
  • Estimated taxes and filing under Schedule C
  • Practical matters – Rutgers and HBA

Jim Coccia
Vice President, U.S. Market Access, TAKEDA


Michele Cole
Director, Health Economics and Outcomes Research, ACTELION


Sanjay Doddamani, M.D.
Chief Medical Officer, GEISINGER LED KEYSTONE ACO

view speaker profile

Dr. Sanjay Doddamani is the Chief Medical Officer of the Geisinger-led Keystone ACO, and a senior director in population health at Geisinger Health System. In this capacity, he works with executive leadership to accelerate improvement of performance metrics across the system working closely with the service line medical directors, platform leaders and operational leadership to improve integration of population health initiatives. He is also the systemwide chief of the Advanced Cardiac Disease – Heart Failure program for Geisinger Health System. His background as a heart failure cardiologist has kept him interested in chronic disease management aspects of heart failure. Additionally, he oversees the LVAD program for mechanical circulatory (heart pump) support. Dr. Doddamani is board certified in Internal Medicine and Cardiology, as well as in heart failure and cardiac transplant. He has served on numerous panels and committees, as well as delivered lectures, both nationally and abroad, related to heart health and disease.


Alan Gilbert
Vice President, Growth, LUMIRADX

view speaker profile

Alan Gilbert is a mission-driven growth serial entrepreneur with “up through the ranks” experience in the healthcare industry. He is viewed as a thought leader in the areas of accountable care solutions and collaborative care, and is a frequent contributor to professional online journals as well as a sought-after speaker at industry conferences. He possesses a clear understanding of the current healthcare landscape, and has conceived and implemented strategies that resulted in new markets, new clients and increased revenue. Alan benefits from having a well-developed network of long-standing relationships at the executive level, with access and credibility to be viewed as their trusted advisor. Alan is focused on the achievement of systematically better health outcomes at lower costs through a TEAM-based approach to care management. Alan is currently the Chief Growth Officer and Co-Founder of TEAM of Care Solutions, LLC, focusing on Technology Enabled Active Management of Care (TEAM). Previous to TEAM of Care Solutions, LLC, Alan was the Co-Founder of AxSys Health, the U.S. operations of a U.K.-based Collaborative Care Technology Care Company called AxSys Technology.


Jeffrey Gold
Senior Vice President and Special Counsel, HEALTH ASSOCIATION OF NEW YORK STATE

view speaker profile

Jeffrey Gold is Senior Vice President and Special Counsel of the Managed Care and Insurance division at HANYS, the Healthcare Association of New York State. Mr. Gold works with the payor community, state and federal regulators, and New York State government to address provider issues and has drafted, negotiated, and helped secure major packages of managed care reform legislation that impact external appeals, administrative denials, claims processing and payor practices. He has designed HANYS’ highly regarded Strategies, Weapons, and Tactics programs (SWAT) and coaches hospitals on denials management and contract negotiation strategies.

Prior to his arrival at HANYS, in 2000, Mr. Gold was Special Counsel for Health Care to the New York State Attorney General. Mr. Gold served four Attorneys General in New York and was the founding Bureau Chief of New York’s Health Care Bureau in 1997. Mr. Gold joined the Attorney General’s office in 1987 and developed his managed care background as a result of overseeing units of the Attorney General’s office at Helen Hayes Hospital in West Haverstraw, New York, Roswell Park Cancer Institute in Buffalo, and the three State University of New York medical centers in Brooklyn, Syracuse, and Stony Brook. Before 1987, he worked at two private law firms in New York City, with a focus on civil litigation.

Mr. Gold has a B.A. from the University of Pennsylvania (1975) and a J.D. from Brooklyn Law School (1979). He is a frequent lecturer at Bar Associations meetings, Health Care Conferences, and HFMA events and has published several articles.


Bob Goldberg
Vice President and Co-Founder, CENTER FOR MEDICINE IN THE PUBLIC INTEREST


Jonathan Harding, M.D.
Senior Medical Director, Senior Products Division, TUFTS HEALTH PLANS


Lance Hill
Chief Executive Officer, WITHIN3

view speaker profile

As Chief Executive Officer of Within3, Lance Hill brings his own brand of energy, leadership and vision to the company.

With the belief that deeper engagement among healthcare professionals results in improved healthcare and better patient outcomes, Lance strategizes with global healthcare decision makers on how to integrate digital collaboration solutions into their businesses as an effective new channel of communication.

Prior to joining Within3, Lance served as the Vice President and General Manager of the worldwide Service Oriented Architecture business unit for the webMethods Corporation, an international leader in enterprise software. With annual revenues exceeding $200 million, webMethods was acquired in 2007 by German giant, Software AG, for $546 million.

Recruited directly from the University of Toledo by tech giant IBM, Lance led the design and implementation of global telecommunication networks for Fortune 500 businesses and major healthcare organizations, as well as consulted and lectured on worldwide technology strategies. He also developed training, methodology and best practices for Global Services consultants. Lance subsequently joined a top 10 U.S. financial services firm where he served as the Vice President of Enterprise Engineering and founded its Fusion Technology Group, dedicated to accelerating corporate adoption of new technologies and business processes.

A veteran in the technology industry, Lance dedicates himself to work he strongly believes in — improving healthcare by providing an easy-to-use, always accessible, digital collaboration solution for healthcare professionals and industry leaders to connect, communicate and collaborate.


Stephen Hull
Principal and Founder, HULL ASSOCIATES LLC

view speaker profile

Stephen Hull is Principal and Founder of Hull Associates LLC, a specialized global reimbursement strategy firm focused on pharmaceutical, medical device, diagnostic and biotech technologies.

With 40 seasoned partners worldwide, Hull Associates LLC develops and executes strategies for reimbursement and product launches in major global markets, including the Americas, the Asia Pacific, Northern and Eastern Europe, the Middle East, and Western Europe.

Stephen Hull has more than 25 years of experience in health policy and medical product strategy, for pharmaceuticals, medical devices, diagnostics and biotech products.

Prior to forming Hull Associates, he served as Senior Vice President for Global Reimbursement at AdvaMed in Washington, D.C., the leading U.S.-based medical technology trade association. Internationally, he designed and launched numerous joint advocacy campaigns, with a primary focus on reimbursement issues, working with sister associations in the major overseas markets.

Before his trade association work, Stephen was a Principal at Covance Health Economics and Outcomes Services, where he executed numerous private and public payor reimbursement and market strategies.

Stephen has also served as chairman of the Medical Devices Council for the International Society for Pharmacoeconomics and Outcomes Research (ISPOR).

Stephen has an advanced degree in health policy from the Johns Hopkins Bloomberg School of Public Health, and a bachelor’s degree in international relations and French from Colgate University.


Michael Hunt
Chief Executive Officer and President, ST. VINCENT’S HEALTH PARTNERS

view speaker profile

Dr. Hunt graduated from the University of Osteopathic Medicine and Health Sciences, Des Moines, Iowa and completed his residency in Pediatrics. During his military service, Dr. Hunt’s held key leadership positions. As Chief Medical Information Officer, he has implemented ‘Epic’ and ‘Cerner’ EMRs. He is Board Certified and received a Master of Science in Medical Informatics.

In April 2013, Dr. Hunt was appointed CPHO (Chief Population Health Officer [CMO/CMIO]) for St. Vincent’s Health Partners, Inc., a Physician Hospital Organization with more than 400 providers, and St. Vincent’s Medical Center. Dr. Hunt provides physician leadership and direction for the planning, design, and implementation of clinical information systems at St. Vincent’s Health Partners, Inc. and oversees quality and utilization for its provider network. Under the leadership of Dr. Hunt, St. Vincent’s Health Partners, Inc. was the first organization in the country to become accredited by URAC as a Clinically Integrated Network and is leading the charge in changing the face of healthcare in CT. Currently, working with organizational leaders, Dr. Hunt is engaged to develop information system infrastructure to support a super clinically integrated network. As interim Chief Executive Officer (2016), he is now focused to develop additional opportunities for medical management with employers.

Dr. Hunt joined St. Vincent’s Health System (SVHS) as CMIO in August 2014. He is working closely with clinical and information technology associates to transition to ongoing operations after the Cerner EMR implementation. Additionally, Dr. Hunt participates with the Valued Care Alliance (a newly formed seven hospital consortium in Connecticut in which St. Vincent’s Medical Center is a founding member) to establish system-wide population management infrastructure. SVHS was the first hospital to attest to stage two Meaningful use in Connecticut and is now optimizing through uplift the Cerner EMR.


Sachin Kamal-Bahl
Vice President and Innovation Center Head, Global Health and Value, PFIZER

view speaker profile

Sachin Kamal-Bahl is currently Vice President and Head of the Global Health and Value Innovation Center at Pfizer Inc. — a newly created organization under Dr Kamal-Bahl’s leadership — that develops and integrates innovative approaches based on well-considered risks and strong technical underpinnings to address the access, pricing or valuation of challenges and opportunities. Dr Kamal-Bahl oversees the group’s strategic efforts aimed to a) help the organization recognize the strategic implications of environmental issues impacting valuation of and access to Pfizer therapies; b) develop and test prototypes and consider systematically embedding them within internal processes of the organization in order to better position Pfizer to demonstrate value and gain market access for assets at launch; c) develop, execute and evaluate innovative experimental approaches in order to address access, pricing or valuation challenges for Pfizer assets being raised by payers and; d) spearhead efforts with strong technical underpinnings to develop and/or support Pfizer’s approach to access, value and shape external practices over time.

Dr. Kamal-Bahl previously was the Executive Director and Global HTA Strategy Head at Merck & Co., Inc., where he provided strategic guidance to senior leadership on aspects related to HTA and its evolving landscape and was responsible for the development of Merck’s positions on key HTA topics. His group was also responsible for translating and executing HTA concepts across all of Merck’s franchises and geographies/regions.

Prior to this role, Dr. Kamal-Bahl was the Global Access Team Leader for the Diabetes and Obesity Franchise in the Global Market Access division at Merck & Co., Inc. In this key strategic role he led a companywide global cross-functional team that was responsible for developing an integrated market access strategy that includes pricing, reimbursement, health economics and outcomes research, health technology assessment, and payer and stakeholder engagement strategies to optimize profitability and market access and coordinate the implementation of this strategy for the entire portfolio of products under the Diabetes and Obesity Franchise.

In other previous roles within the company, Dr. Kamal-Bahl has worked in the Global Strategic Pricing area where he was a Global Strategic Pricing Leader responsible for developing the pricing strategies for all products under the diabetes and obesity franchise. In the past he has also led the development of health economics, outcomes research, market access and reimbursement strategies supporting the cardiovascular and metabolic franchises in leveraging the value proposition for cardiovascular, diabetes and obesity products within the US Outcomes Research & Management and Global Outcomes Research departments at Merck & Co., Inc.

Dr. Kamal-Bahl is a clinically trained pharmacist who obtained a Ph.D. in pharmaceutical health services research at the University of Maryland, Baltimore, MD. He currently also holds positions as Adjunct Senior Fellow at the Leonard Davis Institute of Health Economics at the University of Pennsylvania and as Adjunct Assistant Professor at the University of Maryland School of Pharmacy.

Dr. Kamal-Bahl is actively involved with several professional organizations such as AcademyHealth, American Heart Association, American Diabetes Association and International Society for Pharmacoeconomics and Outcomes Research. He has also published in several journals such as American Journal of Cardiology, American Heart Journal, Archives of Internal Medicine, Archives of Pediatrics and Adolescent Medicine, Diabetes Care, Endocrine Practice, Health Affairs, International Journal of Obesity, Journal of the American Geriatrics Society, Obesity, and Preventing Chronic Disease.


Michael Kaminsky
Director, Value-Based Care Strategy, AETNA

view speaker profile

Michael Kaminsky is currently the Director of Value-Based Care Strategy for the Texas market with Aetna. He oversees ~30 Commercial and Medicare value-based partnerships in the state encompassing ~450,000 members. Previously, he was a Senior Manager in the Joint Venture Strategy and Business Development group, forming advanced partnerships with health systems, including the Texas Health + Aetna joint venture in Dallas-Fort Worth. Prior to Aetna, Michael worked at The Boston Consulting Group (BCG). He graduated from Brandeis University with a Bachelor’s degree in Health: Science, Society, and Policy.


Brian McGarry
Market President, AETNA

view speaker profile

Brian is the President of National Accounts in Pennsylvania, Delaware, New Jersey, Virginia, Maryland, West Virginia and DC. He has oversight for Sales and Service associated with some of Aetna’s largest prospects and customers within Aetna’s large employer business. He has all P+L accountability for all lines of coverage and products. Before being promoted to President in 2003, Brian was the Vice President Sales and Service of Mid?Atlantic National Accounts.

Brian joined Aetna in March of 1996 as the Eastern U.S. Sales Director in Corporate Health Administrators – a wholly owned subsidiary of Aetna. In that role, he was responsible
for directing a sales team focused on the sale of mid and large sized self?insured employee benefit programs throughout the East Coast. Later that year, Brian’s role was expanded to include all of the US. In 2000, he joined National Accounts in Philadelphia as Director of Sales and Service.

Prior to joining Aetna, Brian spent 12 years at Prudential Healthcare in a variety of progressively responsible Sales and Sales Management positions throughout Southeastern United
States. Immediately prior to joining Aetna, he was the Director of Marketing for Prudential in Virginia.

Over the years, Brian has participated on a number of charitable and business related boards in the Greater Philadelphia area. He is an immediate past board member of the American Heart Association, a member of their Executive Leadership Team for the Heart Ball, and a past Chairman of the Philadelphia Heart Walk – the largest single fundraising event for the AHA. Brian is a past Board member of the Greater Philadelphia Economy League ? a private/public partnership advancing business in the Area. Brian is a frequent speaker on a variety of health care and business topics such as the business case for wellness and employee engagement.

Brian graduated from the University of Scranton with a B.S. in Business Management and Marketing.


Charles Pak
Senior Director, New Product Planning, IMMONOGEN, INC.

view speaker profile

Charlie has more than 15 years of commercial experience in the biopharmaceutical industry. He has led global launch teams in oncology and hepatology and has marketed specialty products in the US, UK and Europe. He is currently responsible for new product planning and commercial launch strategy for a Phase III compound for ovarian cancer.

Prior to ImmunoGen, Charlie was at Shire, Eisai, Vertex and Bristol-Myers Squibb.


Jamie Partridge
Director, Global Scientific Affairs, ABBOTT

view speaker profile

Jamie Partridge, Director, Global Scientific Affairs at Abbott Nutrition leads a team focusing on Scientific External Engagement, Health Economics and Outcomes Research, Public Health and Policy. Jamie joined Abbott Nutrition in 2012 and established its HEOR group which focuses on initiatives in the area of therapeutic nutrition to demonstrate nutrition intervention and process-improvement as a cost-effective way of improving health outcomes. Jamie came to Abbott Nutrition from Abbott Vascular’s HEOR team, where she supported ABSORB™ Bioresorbable Scaffolds, XIENCE Drug-Eluding Stents, and the MitraClip Mitral Valve Repair System. Prior to working in industry, Jamie was a researcher in the Center for Health Outcomes, Policy and Evaluation Studies in the College of Public Health at the Ohio State University and served as a faculty member at a variety of universities including the Ohio State University, University of Saskatchewan, St. John’s University, Georgia Southern University and the University of Montana.

Jamie has a B.A. in Economics from the University of Illinois, an M.B.A in Finance and Operations Management from Indiana University’s Kelley School of Business, and a Ph.D. in Agricultural Economics from the University of Saskatchewan.


Steven Peskin
Healthcare Delivery Innovation, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY

view speaker profile

Dr. Steven R. Peskin is the Executive Medical Director Population Management at Horizon Blue Cross Blue Shield of New Jersey. His expertise encompasses physician leadership; medical delivery management; performance improvement in healthcare; contracting; applications in technology, including mobile/social media; and clinical/scientific communications for healthcare professional and consumer audiences.

Dr. Peskin is the former Executive Vice President and Chief Medical Officer for MediMedia USA, CEO of Pharmaceutical Research Plus, and President/COO of Nelson Managed Solutions. He has worked in multiple executive positions in health plans at PacifiCare Health Systems, CIGNA Healthcare and John Hancock. Dr. Peskin has authored industry and scientific articles as well as book chapters, and has spoken at various conferences and events about physician leadership, the medical home, mobile health and social media.

Dr. Peskin continues to work at the Rutgers Robert Wood Johnson School of Medicine as a clinical preceptor and instructor at the Eric B. Chandler Clinic and assists in the business of medicine curriculum. He is Course Director for Internal Medicine Grand Rounds at The University Medical Center in Princeton. He has held faculty appointments in medicine at several universities across the country and is currently an Associate Clinical Professor of Medicine Rutgers Robert Wood Johnson School of Medicine.

Dr. Peskin is a diplomat of the American Board of Internal Medicine and a fellow of the American College of Physicians, serves as governor for the Southern Region of the ACP in New Jersey, Board of Trustees for Friends of the National Library of Medicine, is on the editorial advisory boards of The Journal of Population Health Management and Managed Care, and is a Senior Scholar in the School of Population Health at Thomas Jefferson University. His community service includes the boards of the Greater Donnelley Neighborhood Initiative and Young Audiences of New Jersey.

Dr. Peskin received a bachelor’s degree from The University of North Carolina Chapel Hill and a medical degree from Emory University School of Medicine. He completed residency at Saint Elizabeth’s Medical Center in Boston and holds an MBA from the Sloan School of Management at Massachusetts Institute of Technology.


Josh Plumb
Senior Director, Payer Marketing, INTARCIA THERAPEUTICS

view speaker profile

Josh Plumb is currently Senior Director of Payer Marketing at Intarcia Therapeutics, Inc. Josh is responsible for developing and implementing marketing strategies and plans for payers, IDNs, and other organized customers. Previously Josh was Market Access Director at Cubist Pharmaceuticals, leading 15 key account managers that spanned the East Coast. Spanning over a decade, Josh held positions of increasing responsibility at Cubist, from Market Access to Marketing to Analytics to Sales. Josh began his career in politics and also spent time in software. He holds an MBA from New York University’s Stern School and a Bachelor’s degree from Bucknell University.


Robert Popovian, Pharm.D.
Vice President, U.S. Government Relations, PFIZER

view speaker profile

Robert Popovian is Vice President, US Government Relations at Pfizer Inc. He brings almost two decades of experience in numerous facets of the biopharmaceutical and healthcare industry with a strong track record of expertise, innovation and results in Health Care Policy and Economics, Government Relations, Medical Affairs, and Strategic Planning.

Robert has published and presented extensively on the impact of biopharmaceuticals and health policies on healthcare costs and clinical outcomes, including authorship in clinical and healthcare delivery journals, and is a published expert source in Los Angeles Times, USA Today, Pink Sheet and Bloomberg News, amongst many others. He also writes a monthly column published in Morning Consult regarding health policy and economic issues relevant to the biopharmaceutical industry. He is a frequent speaker at healthcare policy and medical conferences on topics such as payment and delivery reform, the use of real-world data, policies that enable biopharmaceutical innovation, and health economics. He currently serves as a board member for the Global Healthy Living Foundation.

He is one of the few researchers who has studied and published both clinical and policy-related economic analysis as well as one of a handful who have studied and published empirical data regarding emerging payment mechanisms in the US healthcare system. He was also one of the first to secure inclusion of health outcomes data regarding labeled indication of a biopharmaceutical.

Robert completed his doctorate in pharmacy and Master of Science in pharmaceutical economics and policy degrees at the University of Southern California with honors. The degree in pharmaceutical economics and policy was the first one conferred by an accredited university in the US. He has also completed a residency in Pharmacy Practice/Adult Internal Medicine and Infectious Diseases at the Los Angeles County – University of Southern California Hospital, where he was the head pharmacy resident (primary area of research: gram negative bacteremia) and a fellowship in Pharmaceutical Economics and Policy at University of Southern California (primary area of research: payment reform).

Robert is married to Maylin Megran Popovian; they have two beautiful daughters, Katrina and Natalya. They have residences both in Los Angeles, CA and Washington, DC.


Michael Ruiz
Vice President, Provider Relations, UCARE

view speaker profile

As UCare’s Vice President of Provider Relations and Contracting, Michael Ruiz leads complex negotiations with providers and develops innovative Medicare and commercial value-based contracting arrangements. He also manages teams and processes to support improved operations and performance at UCare.

Ruiz was most recently Vice President, Medicare Market Performance at UnitedHealthcare in Minnetonka, Minn. His responsibilities included overseeing value-based contracting analysis for incentive programs, addressing gaps in Medicare Star Ratings and improving medical cost performance for health plan members.

He previously held positions as Senior Director, Accountable Care Strategy at UnitedHealthcare; Senior Provider Contract Manager with Blue Cross Blue Shield of Minnesota in Eagan, Minn.; Project Manager with Medical Management, Inc., of Portland, Ore.; and Hospital Director with Banfield Pet Hospitals in the Twin Cities area.

Ruiz earned a Bachelor of Arts degree from the University of Minnesota. He is a member of the Health Care Financial Management Association. Ruiz and his family live in St. Paul, Minn., where he coaches the Mendota Heights Athletic Association Football, Highland Hoops Basketball League, and Hi-Mac Baseball League, and is president of the Friends of the Oxford Pool.


Marie Sanchirico
Director, Medical Managed Care, SANOFI GENZYME

view speaker profile

Marie Sanchirico. Ph.D. is a value and access medical professional and PhD immunologist currently working as a national Medical Managed Care Director at Sanofi Genzyme in complex specialty drug care division. Prior to joining Sanofi medical affairs, Marie was an associate professor at UMASS Medical School and Instructor of Medicine at Harvard Medical School. Marie received her bachelor’s degree in biochemistry at Ithaca College, her PhD from UMASS, Amherst and specialty trained in immunology as an NIH postdoctoral fellow and Instructor of medicine at Harvard Medical school/Dana Farber Cancer Institute. Marie has three daughters (ages 15, 13 and 9) and is a dedicated hot yogi and outdoor enthusiast.


Lou Savant
Director of Market Access and Reimbursement, OSIRIS THERAPEUTICS, INC.

view speaker profile

Lou Savant is Director of Market Access and Reimbursement at Osiris Therapeutics, Inc. Lou is responsible for developing market access strategies and partnerships with payers and employer groups. He leads a nationwide team of Regional Account Managers and oversees Osiris’s on-site reimbursement services department. Lou brings over 25 years of pharmaceutical and biotechnology industry experience in multiple areas including clinical research, HEOR, business development, sales management, marketing and market access. Prior to joining Osiris, Lou was with TAP Pharmaceuticals and Takeda Pharmaceuticals. Lou began his career as an exercise physiologist in cardiac rehabilitation and developed corporate health and wellness programs. He holds a B.S. degree in Nutrition and Exercise Science from Penn State University.


Kris Thiruvillakkat
Director, Global Market Access Strategy, PFIZER


Anthony Vespa
Executive Director, SOUTHEAST MICHIGAN ACCOUNTABLE CARE

view speaker profile

Mr. Vespa is a certified public accountant and attorney with experience in the areas of real estate, manufacturing, banking, corporate finance, healthcare and tax. He received his B.A. from Hillsdale College and his J.D. from the University of Detroit School of Law.

Mr. Vespa serves as the Executive Director of Southeast Michigan Accountable Care (SEMAC) since its inception. His efforts were instrumental in the initial formation of SEMAC and its initiatives with Centers for Medicare and Medicaid.


Pritpal Virdee
Senior Vice President and Chief Operating Officer, Senior Health Services, BLUE CROSS BLUE SHIELD MICHIGAN


Christine Burke Worthen
Partner, PIERCE ATWOOD LLP